Brief: AcelRx Pharmaceuticals To Acquire Lowell Therapeutics And Reports Third Quarter 2021 Financial Results

Talphera

15/11/2021 11:12

Nov 15 (Reuters) - AcelRx Pharmaceuticals Inc  ACRX.O :
    * ACELRX PHARMACEUTICALS TO ACQUIRE LOWELL THERAPEUTICS AND
REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
    * Q3 LOSS PER SHARE $0.07
    * AGREEMENT TO ACQUIRE LOWELL IN A TRANSACTION VALUED AT
APPROXIMATELY $32.5 MILLION
    * AGREEMENT TO ACQUIRE LOWELL IN A TRANSACTION VALUED AT
APPROXIMATELY $32.5 MILLION
    * ACELRX - AMOUNT OF SHARES OF ACELRX COMMON STOCK VALUED AT
APPROXIMATELY $6.5 MILLION IS EXPECTED TO BE ISSUED TO LOWELL
SECURITYHOLDERS AT CLOSING

Source text for Eikon:  ID:nPn8nvV2Fa 
Further company coverage:  ACRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))